1- SANTOS N L, BUSTOS S O, BHATT D, CHAMMAS R, ANDRADE L N S. Tumor-Derived Extracellular Vesicles: Modulation of Cellular Functional Dynamics in Tumor Microenvironment and Its Clinical Implications. Front Cell Dev Biol. 2021 9:737449, 2021.

2- SAITO R F, RANGEL M C, HALMAN J R, CHANDLER M, de SOUSA ANDRADE L N, ODETE-BUSTOS S, FURUYA T K, CARRASCO A G M, CHAVES-FILHO A B, YOSHINAGA M Y, MIYAMOTO S, AFONIN K A, CHAMMAS R. Simultaneous silencing of lysophosphatidylcholine acyltransferases 1-4 by nucleic acid nanoparticles (NANPs) improves radiation response of melanoma cells. Nanomedicine; 36:102418, 2021.

3- ANDRADE, L N S; OTAKE, A H; CARDIM, S G B; DA SILVA, F I; IKOMA-SAKAMOTO, M M; FURUYA, T K; UNO, M; PASINI, F S; CHAMMAS, R. Extracellular Vesicles Shedding Promotes Melanoma Growth in Response to Chemotherapy. Scientific Reports. v.9, p.14482, 2019. Fator de Impacto (2017 JCR): 4,1220. doi: 10.1038/s41598-019-50848-z.

4- JANDREY, E H F; MOURA, R P; ANDRADE, L N S; MACHADO, C L; CAMPESATO, L F; LEITE, K R M; INOUE, L T; ASPRINO, P F; DA SILVA, A P M; DE BARROS, A C S D; CARVALHO, A; DE LIMA, V C; CARRARO, D M; BRENTANI, H P; DA CUNHA, I W; SOARES, F A; PARMIGIANI, R B; CHAMMAS, R; CAMARGO, A A.; COSTA, E T. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. npj Breast Cancer., v.5, p.11, 2019. Fator de Impacto (2018): 6,2. doi: 10.1038/s41523-019-0106-x.

5- CIRILO, P DA R*; DE SOUSA ANDRADE, L N*; CORRÊA, B R S; QIAO, M; FURUYA, T K; CHAMMAS, R†; PENALVA, L O F†. MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1. BMC Cancer. v.17, p.750, 2017. * Both authors contributed equally for this work. † Both authors supervised equally this work. Fator de impacto: 2,9. doi: 10.1186/s12885-017-3721-7.